HealthQuill Drugs
The number of sequences to detect the presence of the Covid-19 viral genome, being shared with WHO, has dropped by more than 90%, and the number of countries sharing them has fallen by a third.
Drugs Health Pharma

Global study uncovers subtle health risks linked to Covid-19 vaccines

HQ Team February 28, 2024: An international team of researchers conducted a large study on the safety of COVID-19 vaccines and found potential.

Read More
Excessive levels of parental involvement and control stem from a worry that their child may come to harm or not do well enough.
Drugs Medical Pharma

Opinion: Which parent are you? ‘Helicopter,’ toxic or stressed?

By Dr Aparna S February 27, 2024: Parents who have adolescents may be tough as old boots, excessively involved in bringing up their.

Read More
An asthma drug, omalizumab, can “significantly” reduce the risk of allergic reactions caused by multiple foods among children and adults in case of accidental exposure, according to a study funded by the US medical research agency.
Drugs Health Pharma

Omalizumab or Xolair can lower risk of food allergies in kids, adults: NIH

HQ Team February 26, 2024: An asthma drug, omalizumab, can “significantly” reduce the risk of allergic reactions caused by multiple foods among children.

Read More
Chronic stress may induce cancer, according to scientists from Cold Spring Harbor Laboratory.
Drugs Health Pharma

Chronic stress may accelerate cancer growth, American scientists say

HQ Team February 26, 2024: Chronic stress may be a factor in spreading cancer, according to scientists from Cold Spring Harbor Laboratory. “Chronic.

Read More
Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug to treat neurodegenerative disease, amyotrophic lateral sclerosis.
Drugs Health Pharma

European regulator backs Biogen’s drug for amyotrophic lateral sclerosis

HQ Team February 24, 2024: Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug.

Read More
A single universal shot of antivenom for snake bites is not far away after scientists found a potent antibody to neutralise neurotoxins from four deadly species found in Africa, Asia and Australia.
Drugs Health Pharma

Toxinologists: Single universal snake antivenom jab is within range

HQ Team February 23, 2024: A single universal shot of antivenom for snake bites is not far away after scientists found a potent.

Read More
Scientists have developed a drug to treat malignant pleural mesothelioma, a fatal form of cancer that affects the lining of organs.
Drugs Health Pharma

Scientists discover drug to treat deadly malignant pleural mesothelioma

HQ Team February 2024: Scientists have developed a drug to treat malignant pleural mesothelioma, a fatal form of cancer that affects the lining.

Read More
AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to boost the North Chicago, Illinois-based company’s presence in the psychiatric and neurological disorder segment.
Drugs Health Medical

The loneliness epidemic: A pervasive global health crisis

HQ Team February 21,2024: Loneliness is a pervasive epidemic affecting the youngest to the oldest, impacting their physical and mental health alike. As.

Read More
Women stand to benefit more than men when they indulge in physical activities as it lowers the risk of premature death or fatal cardiovascular events, according to a study conducted by the US-based National Institutes of Health.
Drugs Health Pharma

Exercises help women more than men, cut risk of premature death

HQ Team February 21, 2024: Women stand to benefit more than men when they indulge in physical activities as it lowers the risk.

Read More
Johnson & Johnson announced that USFDA had approved a bi-weekly dose of its blood cancer therapy Tecvayli.
Drugs Health Pharma

Johnson & Johnson’s blood cancer medicine cleared for bi-weekly use

HQ Team February 21, 2024: Johnson & Johnson announced that USFDA had approved a bi-weekly dose of its blood cancer therapy Tecvayli. The regulatory.

Read More